Feasibility and acceptability of implementing early infant diagnosis of HIV in Papua New Guinea at the point of care: a qualitative exploration of health worker and key informant perspectives.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 11 2020
Historique:
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 11 3 2021
Statut: epublish

Résumé

Early infant diagnosis (EID) of HIV and timely initiation of antiretroviral therapy can significantly reduce morbidity and mortality among HIV-positive infants. Access to EID is limited in many low-income and middle-income settings, particularly those in which standard care involves dried blood spots (DBS) sent to centralised laboratories, such as in Papua New Guinea (PNG). We conducted a qualitative exploration of the feasibility and acceptability of implementing a point-of-care (POC) EID test (Xpert HIV-1 Qualitative assay) among health workers and key stakeholders working within the prevention of mother-to-child transmission of HIV (PMTCT) programme in PNG. This qualitative substudy was conducted as part of a pragmatic trial to investigate the effectiveness of the Xpert HIV-1 Qualitative test for EID in PNG and Myanmar. Semistructured interviews were undertaken with 5 health workers and 13 key informants to explore current services, experiences of EID testing, perspectives on the Xpert test and the feasibility of integrating and scaling up POC EID in PNG. Coding was undertaken using inductive and deductive approaches, drawing on existing acceptability and feasibility frameworks. Health workers and key informants (N=18) felt EID at POC was feasible to implement and beneficial to HIV-exposed infants and their families, staff and the PMTCT programme more broadly. All study participants highlighted starting HIV-positive infants on treatment immediately as the main advantage of POC EID compared with standard care DBS testing. Health workers identified insufficient resources to follow up infants and caregivers and space constraints in hospitals as barriers to implementation. Participants emphasised the importance of adequate human resources, ongoing training and support, appropriate coordination and a sustainable supply of consumables to ensure effective scale-up of the test throughout PNG. Implementation of POC EID in a low HIV prevalence setting such as PNG is likely to be both feasible and beneficial with careful planning and adequate resources. 12616000734460.

Identifiants

pubmed: 33444219
pii: bmjopen-2020-043679
doi: 10.1136/bmjopen-2020-043679
pmc: PMC7678362
doi:

Types de publication

Journal Article Pragmatic Clinical Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e043679

Investigateurs

Stanley Luchters (S)
Suzanne Crowe (S)
Mark Stoové (M)
David Anderson (D)
Claire Nightingale (C)
Paul Agius (P)
Yasmin Mohamed (Y)
Hla Htay (H)
Win Lei Yee (WL)
Angela Kelly-Hanku (A)
Andrew Vallely (A)
Steven Badman (S)
Zure Kombati (Z)
Tin Maung Zaw (TM)
Xiang-Sheng Chen (XS)
Htay Htay Tin (HH)
Win Thein (W)
Latt Latt Kyaw (LL)
Janet Gare (J)
Selina Silim (S)

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

HIV Med. 2013 Oct;14 Suppl 3:10-4
pubmed: 24033896
Lancet. 2016 Jan 30;387(10017):491-504
pubmed: 26869576
Lancet HIV. 2017 Oct;4(10):e442-e448
pubmed: 28711526
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):e122-8
pubmed: 21224736
Open AIDS J. 2008;2:17-25
pubmed: 18923696
N Engl J Med. 2008 Nov 20;359(21):2233-44
pubmed: 19020325
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S66-S75
pubmed: 28398999
Int J Health Plann Manage. 2018 Jan;33(1):e367-e377
pubmed: 28960552
Lancet HIV. 2019 Jun;6(6):e373-e381
pubmed: 30987937
J Virol Methods. 2016 Mar;229:35-9
pubmed: 26709099
Int Breastfeed J. 2013 Jun 07;8(1):6
pubmed: 23742201
Pediatr Infect Dis J. 2015 Mar;34(3):273-5
pubmed: 25742076
Trop Med Int Health. 2007 Feb;12(2):162-73
pubmed: 17300622
BMC Health Serv Res. 2016 Aug 02;16(a):343
pubmed: 27484023
BMC Med. 2011 May 20;9:59
pubmed: 21599888
PLoS One. 2017 Dec 20;12(12):e0189226
pubmed: 29261707
PLoS One. 2018 Feb 7;13(2):e0190874
pubmed: 29415011
Acta Paediatr. 2015 Dec;104(467):3-13
pubmed: 26249674
Implement Sci. 2012 Jan 23;7:5
pubmed: 22269037
Sex Transm Infect. 2006 Dec;82 Suppl 5:v1-6
pubmed: 17151023
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):523-31
pubmed: 18989227
PLoS Med. 2012;9(9):e1001306
pubmed: 22973183

Auteurs

Yasmin Mohamed (Y)

Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia yasmin.mohamed@burnet.edu.au.
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Martha Kupul (M)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Janet Gare (J)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Steven G Badman (SG)

The Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, New South Wales, Australia.

Selina Silim (S)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Andrew J Vallely (AJ)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
The Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, New South Wales, Australia.

Stanley Luchters (S)

Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Public Health and Primary Care, International Centre for Reproductive Health, Ghent University, Ghent, Belgium.
Department of Population Health, Aga Khan University, Nairobi, Kenya.

Angela Kelly-Hanku (A)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
The Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH